Spero Therapeutics
SPRO
SPRO
100 hedge funds and large institutions have $180M invested in Spero Therapeutics in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
35% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 23
43% less capital invested
Capital invested by funds: $316M → $180M (-$137M)
Holders
100
Holding in Top 10
2
Calls
$219K
Puts
$15K
Top Buyers
| 1 | +$2.76M | |
| 2 | +$1.94M | |
| 3 | +$949K | |
| 4 |
Two Sigma Investments
New York
|
+$686K |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$609K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$2.31M | |
| 3 | -$560K | |
| 4 |
IA
IndexIQ Advisors
New York
|
-$459K |
| 5 |
WJWM
Williams Jones Wealth Management
New York
|
-$426K |